Carlson Capital’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-23,000
| Closed | -$373K | – | 172 |
|
|
2020
Q1 | $373K | Sell |
23,000
-64,500
| -74% | -$1.05M | 0.01% | 191 |
|
|
2019
Q4 | $1.58M | Buy |
87,500
+29,276
| +50% | +$527K | 0.03% | 201 |
|
|
2019
Q3 | $1.18M | Sell |
58,224
-96,776
| -62% | -$1.96M | 0.02% | 207 |
|
|
2019
Q2 | $3.43M | Sell |
155,000
-340,365
| -69% | -$7.52M | 0.05% | 219 |
|
|
2019
Q1 | $6.76M | Sell |
495,365
-1,224,171
| -71% | -$16.7M | 0.12% | 189 |
|
|
2018
Q4 | $15.6M | Buy |
+1,719,536
| New | +$15.6M | 0.24% | 129 |
|
|
2017
Q4 | – | Sell |
-728,419
| Closed | -$9.72M | – | 221 |
|
|
2017
Q3 | $9.72M | Sell |
728,419
-290,064
| -28% | -$3.87M | 0.17% | 165 |
|
|
2017
Q2 | $14.6M | Sell |
1,018,483
-188,318
| -16% | -$2.7M | 0.21% | 147 |
|
|
2017
Q1 | $25.5M | Buy |
1,206,801
+806,139
| +201% | +$17M | 0.32% | 99 |
|
|
2016
Q4 | $11.3M | Buy |
+400,662
| New | +$11.3M | 0.14% | 177 |
|